By Gina Shaw
Anticipated shortages of intravenous immune globulin (IVIG) as a result of fewer plasma donations during the COVID-19 pandemic have yet to occur, but experts say it’s likely these shortages have only been delayed by a corresponding decreased demand for IVIG during the past several months.
JANUARY 22, 2021